on a twofold dilution series, the a priori inaccuracy may approach 100% for a single isolate. In the current study, the inaccuracy was reduced to <20% by use of five overlapping twofold dilutions series (Aliabadi & Lees, 2001; Sidhu, Landoni, Aliabadi, Toutain, & Lees, 2011) . Secondly, the physiological relevance of in vitro methods using artificial media, such as cation-adjusted Mueller-Hinton broth (CAMHB), has been questioned for some drug classes, including tetracyclines and macrolides. For these classes, MICs for most pathogens are markedly dependent on the growth medium (Brentnall, Cheng, McKellar, & Lees, 2012; Buyck et al., 2012; Dorey, Hobson, & Lees, 2016; Lees, Illambas, Pelligand, & Toutain, 2016; Lees et al., 2015; Toutain et al., 2017) . For the same drug and similar testing conditions (inoculum size and incubation time), the differences in MIC (on a free-concentration basis) between the aforementioned media could be related solely to rates of bacterial growth and death in each medium (Mouton & Vinks, 2005) . Dalhoff (2018) commented that the impact of media protein on AMD activity is multifaceted, influencing cell permeability to the AMD and growth of the organism. Using physiological fluids, such as foetal bovine serum (FBS) and inflammatory exudate or an equivalent designed for eukaryotic cell culture, such as Roswell Park Memorial Institute (RPMI) medium, may provide useful, alternatives to those broths, which are formulated not to mimic conditions in vivo but to facilitate bacterial growth in vitro (Buyck et al., 2012) .
When established clinical breakpoints are not available for a given AMD, those available for structurally related members of the same drug class have been used. For example, when information on the efficacy of oxytetracycline is not available, tetracycline has been used to represent other drugs of the same class.
As culture sensitivity testing panels may only include tetracycline and/or doxycycline, this study compared MICs and MBCs of tetracycline, oxytetracycline and doxycycline for two calf pneumonia pathogens.
The objective was to identify, for six isolates each of M. haemolytica and P. multocida in three matrices (CAHMB, FBS and RPMI) , if the growth medium, based on comparative static growth curves, impacts on susceptibility and MIC. MICs and MBCs were determined not only using twofold standardized dilution series (Clinical and Laboratory Standards Institute CLSI, 2013) but also using five overlapping twofold dilution series. A secondary objective was to identify whether using five overlapping twofold dilution series impacts on tetracycline as an appropriate susceptibility benchmark for oxytetracycline.
| MATERIAL S AND ME THODS

| Selection and storage of bacterial strains
Six strains each of M. haemolytica and P. multocida, previously shown to grow logarithmically in MHB and FBS, were recovered from −70°C storage (medium glycerol:milk:water, 20:10:70). These strains were clinical isolates derived from non-related cases of calf pneumonia within the UK; they had been used in a previous study and were known to be sensitive to oxytetracycline (Lees et al., 2015) . Strains were stored at −70°C in brain heart infusion (BHI) broth containing 25% glycerol for the duration of the study. 
| Culture methods
| Antimicrobial drug preparation and storage
Stock drug solutions of tetracycline hydrochloride (#10460264, Fisher Scientific, UK) and oxytetracycline hydrochloride (#O5875, Sigma, UK) were prepared to concentrations of 10 mg/ml in deionized water, and doxycycline monohydrate (#15580594, Fisher Scientific, UK) was prepared to 2 mg/ml in ethanol. Concentrations refer to base molecules. All solutions were filter sterilized using a 0.22 μm syringe filter. Weighing of drug powders was adjusted according to the potency calculations outlined in the CLSI guidelines (CLSI, 2013) . Aliquots of 1 ml were stored in amber microcentrifuge tubes at −20°C.
| Determination of MIC and MBC
Minimum inhibitory concentrations were determined in accordance with CLSI standards (CLSI, 2013) . The CLSI twofold dilution series (0.0625-32 μg/ml) method was adapted; four additional overlapping dilution series (0. 04375-22.4, 0.05-25.6, 0.05625-28.8, 0.0625-32, 0.075-38 .4 μg/ml) were used to improve the accuracy of MIC and MBC measurements (Sidhu et al., 2011) . Dilutions of AMDs were prepared in broths (CAMHB and RPMI) or FBS at the aforementioned concentrations. In FBS, free drug fractions were calculated from protein-binding data, using values of 31% for tetracycline (Papich & Riviere, 2009; Ziv & Sulman, 1972) , 50% for oxytetracycline (Brentnall, Cheng, McKellar, & Lees, 2013; Pilloud, 1973) and 92% for doxycycline (Riviere & Papich, 2018) . For RPMI, MICs could be determined for P. multocida only after supplementation with 0.1 M phosphate, pH 6.8, according to the method previously described (Sun & Clinkenbeard, 1998) . M. haemolytica MIC could not be determined in RPMI, as it could not be grown without adding a proportion of FBS of at least 0.1%. MIC tests were repeated a minimum of three times, on separate days, and mean MIC values were calculated.
Minimum bactericidal concentration was determined by a spotplate method. A 10 μl sample from each well, equal to and exceeding the MIC, was spotted onto a Mueller-Hinton agar plate and incubated overnight at 37°C. Plates were inspected for growth, and MBC was recorded as the point at which no growth occurred.
| Growth curves
Static growth curves of P. multocida were performed in each of the three growth media. Each strain was grown overnight (14-16 hr) in BHI broth at high-density logarithmic growth. A 100 μl aliquot of the suspension was transferred into 5 ml of either FBS, CAMHB or RPMI (supplemented with 0.1 M phosphate, pH 6.8). Each inoculated medium was then incubated at 37°C in a shaking incubator at 150 rpm. Samples were taken at 0, 1, 2, 4, 8, 24 hr and viable cell counts performed using a spot-plate method, in which a ten-fold dilution series was prepared and three 10 μl drops were spotted onto a Mueller-Hinton agar plate. Following drying and overnight incubation, colonies were counted and counts adjusted for the dilution factor.
| Statistical analyses
Minimum inhibitory concentration and MBC are reported as geometric means and standard deviations. Concentration data were transformed to compensate for the doubling dilution series by ln (2) transformation prior to statistical analysis and presented graphically on an ordinate axis with a ln (2) 
| RE SULTS
| Matrix effect
Following correction of FBS values for protein binding, there were highly significant differences between media in geometric mean MIC and MBC values for P. multocida for all drugs, tetracycline, oxytetracycline and doxycycline (Table 1, Figure 1 ). Compared to MICs determined in CAMHB (the standard CLSI-proposed medium for determination of MIC for P. multocida) MICs in FBS were significantly higher with ratios (FBS:CAMHB) of 6.7:1, 7.0:1 and 1.3:1 for tetracycline, oxytetracycline and doxycycline, respectively. For tetracycline and oxytetracycline, MICs in RPMI were significantly lower than those determined in both FBS and CAMHB. In RPMI, MICs for tetracycline were 5.4x, and for oxytetracycline 3.4x lower than in CAMHB. Consequently, ratios FBS:RPMI, of 36.1:1 for tetracycline and 23.8:1 oxytetracycline were even higher than FBS:CAMHB ratios.
Inter-strain variability in MBCs was greater than MIC variability for each drug in each medium. However, the order of potency (most to least) for MBCs was the same as MICs, namely RPMI>CAMHB>FBS for all drugs, and MBC ratios FBS:CAMHB and FBS:RPMI exceeded unity but were smaller in magnitude than corresponding MIC ratios.
For M. haemolytica and all tetracyclines, MICs were significantly higher in FBS (corrected for protein binding) than in CAMHB. Thus, FBS:CAMHB ratios were 10.5:1, 7.7:1, and 1.7:1, respectively, for tetracycline, oxytetracycline and doxycycline. As with P. multocida, there was greater inter-strain variability in MBCs compared to MICs.
However, MBCs were again higher in FBS compared to CAMHB for tetracycline and oxytetracycline. In summary, for both pathogens, the growth medium exerted a highly significant (p < 0.001) impact on MICs and MBCs for all drugs (Figure 1 ).
| Influence of matrix on bacterial growth rate
The rate and magnitude of bacterial growth in the absence of drugs were determined using static growth curves. Comparison of the three media indicated that the support of growth of six isolates of P. multocida was consistently higher in FBS compared with TA B L E 1 Geometric mean free drug concentration (μg/ml) MIC, MBC and standard deviation (SD, n = 6) for tetracycline, oxytetracycline and doxycycline, measured in CAMHB, FBS CAMHB (Figure 2 ). Thus, bacterial counts were significantly higher from 8 to 24 hr (p < 0.01) for FBS. RPMI (supplemented with 0.1 M phosphate, pH 6.8) was relatively poor in supporting the growth of P. multocida, compared with both FBS and CAMHB. Bacterial counts were significantly higher for the latter two media than with RPMI at all time points after inoculation (p < 0.05). Therefore, the medium providing the highest bacterial growth rate (FBS) had highest MIC and MBC values for these tetracyclines, whilst the medium with lowest growth rate (RPMI) had the lowest MICs and MBCs.
| Method effect
Differences in drug potency/efficacy between tetracycline, oxytet- Information Tables S1, S2 and Figures S1, S2), there were no significant differences between the MICs for tetracycline and oxytetracycline against M. haemolytica in CAMHB, whereas the 5-dilution series revealed statistically significant differences between all three drugs. For P. multocida, however, the twofold dilution series gave the same conclusion as the 5-overlapping dilution series, namely that doxycycline was significantly more potent than tetracycline and oxytetracycline, whilst tetracycline and oxytetracycline did not differ significantly. 
| D ISCUSS I ON
| Comparison of FBS and CAMHB for MIC and MBC determination
The literature cites many examples of differences in MIC measured, on the one hand, in broths using the internationally recognized Differences in MIC between serum and broths are not limited to P. multocida and M. haemolytica or to calf and pig pathogens.
Comparing MICs for a range of tetracyclines in broth and 50% broth:
about 50% serum (both mouse and human serum) for S. pneumoniae and S. aureus revealed increased MICs in the serum: broth mixed matrix compared with broth (Honeyman et al., 2015) .For 12 tetracyclines and 10 strains of S. aureus, increased MICs were obtained in the presence of serum and, for seven of these compounds, the increase was in the range of 8-to 128-fold. Honeyman et al. (2015) did not correct for protein binding in their study but, as they explored multiple tetracyclines under the same conditions, if protein binding were the only influencing factor it would be predicted that MIC proportional differences would be obtained consistently. They The strains selected for this study were previously shown to grow logarithmically in both FBS and CAMHB. However, comparing growth curves in the absence of AMD in this study, maximal viable cell counts after 8 and 24 hr incubation were higher for FBS than CAMHB, which in turn was higher than RPMI. The capacity to support bacterial growth, correlating with numerical MIC values, suggests that bacterial growth rate, and therefore bacterial burden achieved, is one and possibly the principal factor determining matrix MIC and MBC differences. This might be attributable to the higher challenge to drug activity with higher bacterial counts with FBS and, conversely, the lower bacterial counts with RPMI providing a lesser challenge to drug inhibitory action.
Whatever the underlying cause of matrix-based potency differences, the present data unequivocally indicate that other matrix-specific factors influence measured MICs, possibly through differences in bacterial growth or death rates. Mouton and Vinks (2005) presented an equation for calculation of MIC, based on several input factors, including growth and kill rates and this model is consistent with the present results, indicating that reducing the net growth rate decreases correlatively with the MIC, other factors being equal.
| Tetracycline as a surrogate for susceptibility testing of oxytetracycline
The standards for determination of MIC and MBC rely on the unproven assumption that, in the absence of defined breakpoints for a given drug, other drugs within the same class will have equal potency. This assumption should be questioned; it is a fundamental principle of pharmacology that two agonist (or antagonist) drugs of differing chemical structures (even very minor differences) acting at the same site (on the same receptor or enzyme) will almost invariably have differing potencies. MICs may differ by several orders of magnitude, as a consequence of differing pharmacodynamic factors, including efficacy (in vitro killing rate), potency (differing concentrations to achieve a given in vitro killing rate) and sensitivity of the concentration/effect relationship. Moreover, as previously discussed, other biochemical factors that are matrix dependent may also be consequential, even when the AMDs share similar antimicrobial actions and physico-chemical properties. As MIC breakpoints are used in conjunction with pharmacokinetic data to predict dosage regimens, it is essential to allow for pharmacodynamic as well as pharmacokinetic differences between drugs of a single class. This study investigated whether tetracycline, the prototypic drug of the class, can be used as a surrogate representative for oxytetracycline.
This study evaluated the impact of using five overlapping twofold dilution series, compared to the widely used single twofold dilution series. For M. haemolytica, analysis of the data by the traditional methodology indicated no significant potency F I G U R E 3 MIC and MBC comparisons for three tetracyclines in FBS, CAMHB, and RPMI. Mean MIC and MBC (μg/ml) for three tetracyclines (doxycycline, oxytetracycline and tetracycline) measured in CAMHB, FBS and RPMI for M. haemolytica and P. multocida after protein-binding correction. *p < 0.001 (analysis of variance with Tukey posthoc analysis). N.S: No significant difference. MIC and MBC determinations were based on 5-overlapping sets of doubling dilutions to increase accuracy differences between the three drugs, when tested in CAMHB.
In contrast, the data obtained from the five overlapping twofold dilution series revealed small but significant differences between tetracycline and oxytetracycline. This implies that standard testing methods may not be sufficiently sensitive to identify small but nevertheless significant potency differences between AMDs of the same class for some bacterial species. Therefore, it is possible that the use of tetracycline as a surrogate for oxytetracycline is inappropriate, due to the limited discriminatory power of the susceptibility assay (single twofold dilution series). However, this
was not always the case. For P. multocida, in both the five overlapping dilution series and the single twofold dilution series, it is concluded that tetracycline and oxytetracycline did not differ significantly in potency.
In summary, the five overlapping twofold dilution series provides a more accurate MIC determination for single or small numbers of isolates. Additionally, it provides a method for identifying minor differences in drug potency that would otherwise not be revealed using standard methods. fluids (e.g., interstitial fluid or inflammatory exudate) it is likely to be more so than CAMHB (Brentnall et al., 2012 (Brentnall et al., , 2013 ).
An important challenge, arising from the present study, is how to standardize estimates of AMD potency (MIC and MBC) in biological fluids such as FBS. It is suggested that future studies should examine the reproducibility of MIC / MBC testing with different FBS batches, possibly from different animal breeds, animals of differing age and in healthy versus diseased animals. The use of FBS is one means of ensuring that serum is not already primed for the organisms being studied, as antibodies are not transferred to the foetus, due to their inhibition by the synepitheliochorial placenta (Borghesi, Mario, Rodrigues, Favaron, & Miglino, 2014) . However, a study by Reiche, Mülling, and Frey (1980) The use of the five overlapping twofold dilution series in this study limits the potential for inaccuracy in MIC measurement to no more than 20% for each isolate. The small number of isolates used, six for each organism, requires confirmation using a larger number of wild-type environmental isolates; future studies will seek to expand on this facet of the work.
| CON CLUS IONS
The results presented in this paper indicate a significant effect of growth matrix on MICs and MBCs of three tetracyclines for two cat- 
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